(NASDAQ: SAEN) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 30.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,555.52%.
Genenta Science Spa's earnings in 2026 is -$7,566,427.On average, 3 Wall Street analysts forecast SAEN's earnings for 2026 to be -$10,994,380, with the lowest SAEN earnings forecast at -$10,563,228, and the highest SAEN earnings forecast at -$11,317,744.
In 2027, SAEN is forecast to generate -$12,667,438 in earnings, with the lowest earnings forecast at -$12,170,676 and the highest earnings forecast at -$13,040,010.